PSA Today 26 Aug: Cyclical stocks help / PSVR2 at TGS / PS5 sales / Sumi Pharma patent cliff; Mitsui Chem divests phenols / Ferrotec firm / Money Forward's gambit – Nikkei 225 +0.57%
Japan Market Comment by Pelham Smithers, Joel Scheiman, William Nestuk and Lindsay WhippTags: Tokyo Electron (8035 JT), Ferrotec (6890 JT), SoftBank Group (9984 JT), Sony (6758 JT), Microsoft (MSFT US), Toray (3402 JT), Kyocera (6971 JT), Toyoda Gosei (7282 JT), Lion Corp (4912 JT), Capcom (9697 JT), Meta (FB US), Apple (AAPL US), Nintendo (7974 JT), Sumitomo Pharma (4506 JT), Roivant Sciences (ROIV US), Sumitomo Chemical (4005 JT), Mitsui Chemicals (4183 JT), INEOS Group, Applied Materials (AMAT US), Money Forward (3994 JT), Sansan Inc (4443 JT), Freee KK (4478 JT), Rakus (3923 JT)
Main Points
• “Up” day in Tokyo as cyclical stocks to the fore
• PSVR2 set to be playable at Tokyo Games Show
• PS5 sales down YoY in latest weekly data
• Sumitomo Pharma’s patent cliff draws nearer
• Mitsui Chemicals to divest phenol operations
• Ferrotec edges up 1% WoW on firm FY22 outlook
• Money Forward launches invoicing product to rival Sansan’s Bill One
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.